國家衛生研究院 NHRI:Item 3990099045/14271
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 909555      Online Users : 794
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/14271


    Title: Discovery of a biomarker signature that reveals a molecular mechanism underlying diabetic kidney disease via organ cross talk
    Authors: Wu, IW;Tsai, TH;Lo, CJ;Chou, YJ;Yeh, CH;Cheng, ML;Lai, CC;Sytwu, HK;Tsai, TF
    Contributors: National Institute of Infectious Diseases and Vaccinology;Institute of Molecular and Genomic Medicine
    Abstract: Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease, and it creates tremendous medical care costs. Accurate prediction of DKD and its potential molecular implications remain incompletely understood. Here, we apply artificial intelligence (AI) algorithms to build up an interaction model that tackles the complex interconnections between diabetes and chronic kidney disease (CKD) and to identify a biomarker signature that predisposes high-risk type 2 diabetes patients to progression to DKD. The cohort in this study contains 618 subjects, and these can be split into training (557 subjects) and testing (61 subjects) cohorts. Their mean age was 63.8 ± 12.9 years, and they included 287 males (46.4%). The median estimated glomerular filtration rate was 83.0 mL/min/1.73 m2. Of the subjects, 338 (54.7%) were control subjects, 112 (18.1%) had type 2 diabetes, 73 (11.8%) had nondiabetic CKD, and 95 (15.4%) had DKD (Fig. 1A). The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Institutional Review Board of Chang Gung Medical Foundation (Institutional Review Board no. 201800802B0, 202000077B0A3, 201800273B0C602, and 202002535B0). Informed consent was obtained from all subjects involved in the study.
    Date: 2022-06-02
    Relation: Diabetes Care. 2022 Jun 2;45(6):e102-e104.
    Link to: http://dx.doi.org/10.2337/dc22-0145
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0149-5992&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000886431800001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85131270593
    Appears in Collections:[Huey-Kang Sytwu] Periodical Articles
    [Others] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PUB35546525.pdf13900KbAdobe PDF205View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback